1. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection;MMWR Morb Mortal Wkly Rep,1986
2. Immune globulins: therapeutic, pharmaceutical and cost considerations;Siegel;Pharm Practice News,2005
3. Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP);MMWR Morb Mortal Wkly Rep,2007
4. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis;Victor;N Engl J Med,2007
5. Recommendations of the Advisory Committee on Immunization Practices (ACIP) postexposure prophylaxis of hepatitis B;MMWR Morb Mortal Wkly Rep,1984